Skip to main content
. Author manuscript; available in PMC: 2020 May 8.
Published before final editing as: JACC Cardiovasc Imaging. 2018 Nov 8:S1936-878X(18)30920-3. doi: 10.1016/j.jcmg.2018.08.038

Table 4:

Adjusted associations between baseline amygdalar activity, hematopoietic system activity and vascular disease in psoriasis cohort.

Variables (N=164) Model-1 Model-2 Model-3
Hematopoietic system activity &amygdalar activity
Spleen activity 0.17 (0.03) 0.12 (0.14) 0.11 (0.16)
Bone marrow activity 0.20 (0.01) 0.19 (0.02) 0.17 (0.03)
Aortic vascular inflammation, NCB & amygdalar activity
Aortic vascular inflammation 0.31 (<0.001) 0.23 (0.002) 0.23 (0.003)
Non-calcified coronary plaque burden 0.27 (<0.001) 0.23 (<0.001) 0.24 (<0.001)

Values reported in Beta (p-value)

Model-1: Unadjusted

Model-2: Adjusted for Framingham risk score

Model-3: Adjusted for Framingham risk score, waist-to-hip ratio, lipid treatment (including statin use), high sensitivity c-reactive protein